Italian interim analysis of NISSO: long-term sonidegib safety in locally advanced basal cell carcinoma. (PubMed, Ital J Dermatol Venerol) - Sep 30, 2026 - P | "All the above supports the use of sonidegib as a manageable first-line systemic treatment in patients with laBCC."
Journal • Basal Cell Carcinoma • Fatigue • Non-melanoma Skin Cancer • Oncology
|
|
Federica De Galitiis; Francesco Spagnolo; Ignazio Stanganelli; Ketty Peris; Lisa Licitra; Loredana Romano; Maria C Fargnoli; Massimiliano Scalvenzi; Michele Guida; Paola Savoia; Paolo A Ascierto; Paolo Bossi; Ramon Arntz; Serena Martelli; Vincenzo De Giorgi
|